1661 related articles for article (PubMed ID: 2465525)
1. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
Kamps MP; Sefton BM
Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
[TBL] [Abstract][Full Text] [Related]
2. Identification of multiple novel polypeptide substrates of the v-src, v-yes, v-fps, v-ros, and v-erb-B oncogenic tyrosine protein kinases utilizing antisera against phosphotyrosine.
Kamps MP; Sefton BM
Oncogene; 1988 Apr; 2(4):305-15. PubMed ID: 2452398
[TBL] [Abstract][Full Text] [Related]
3. Evidence that a phosphotyrosine-containing 120,000 Da protein from Rous sarcoma virus-infected cells is phosphorylated by pp60v-src.
Lau AF
Oncogene Res; 1989; 4(3):185-94. PubMed ID: 2472591
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of GAP and GAP-associated proteins by transforming and mitogenic tyrosine kinases.
Ellis C; Moran M; McCormick F; Pawson T
Nature; 1990 Jan; 343(6256):377-81. PubMed ID: 1689011
[TBL] [Abstract][Full Text] [Related]
5. Src homology 2 domain deletion mutants of p60v-src do not phosphorylate cellular proteins of 120-150 kDa.
Wendler PA; Boschelli F
Oncogene; 1989 Feb; 4(2):231-6. PubMed ID: 2494631
[TBL] [Abstract][Full Text] [Related]
6. Localization of major potential substrates of p60v-src kinase in the plasma membrane matrix fraction.
Hamaguchi M; Hanafusa H
Oncogene Res; 1989; 4(1):29-37. PubMed ID: 2497423
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of the transforming protein of Rous sarcoma virus: direct demonstration of phosphorylation of serine 17 and identification of an additional site of tyrosine phosphorylation in p60v-src of Prague Rous sarcoma virus.
Patschinsky T; Hunter T; Sefton BM
J Virol; 1986 Jul; 59(1):73-81. PubMed ID: 2423705
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of reversion of Rous sarcoma virus transformation by herbimycin A: reduction of total phosphotyrosine levels due to reduced kinase activity and increased turnover of p60v-src1.
Uehara Y; Murakami Y; Sugimoto Y; Mizuno S
Cancer Res; 1989 Feb; 49(4):780-5. PubMed ID: 2463877
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the cellular src protein tyrosine kinase: interactions of the carboxyl terminal sequences residing between the kinase domain and tyrosine-527.
Cobb BS; Parsons JT
Oncogene; 1993 Nov; 8(11):2897-903. PubMed ID: 7692368
[TBL] [Abstract][Full Text] [Related]
10. From c-src to v-src, or the case of the missing C terminus.
Sefton BM; Hunter T
Cancer Surv; 1986; 5(2):159-72. PubMed ID: 2430701
[TBL] [Abstract][Full Text] [Related]
11. Characterization of avian retroviruses carrying activated transforming human c-src genes and of steps involved in expression of activated src-PKases in vitro.
Tanaka A; Salem M; Eckroade RJ; Fujita DJ
Oncogene Res; 1990; 5(4):305-22. PubMed ID: 2168536
[TBL] [Abstract][Full Text] [Related]
12. Decrease in coupling of Gs in v-src-transformed NIH-3T3 fibroblasts: possible involvement of tyrosine phosphorylation of Gs by pp60v-src.
Akiho H; Tokumitsu Y; Noda M; Nomura Y
Arch Biochem Biophys; 1993 Jul; 304(1):235-41. PubMed ID: 7686735
[TBL] [Abstract][Full Text] [Related]
13. Characterization of avian and viral p60src proteins expressed in yeast.
Kornbluth S; Jove R; Hanafusa H
Proc Natl Acad Sci U S A; 1987 Jul; 84(13):4455-9. PubMed ID: 2440023
[TBL] [Abstract][Full Text] [Related]
14. The oncogenic protein p60v-src has competence activity but does not activate phosphatidylinositol turnover or protein kinase C in Balb/c 3T3 cells.
Han JW; Gaut J; Burstein E; Sadowski H; Young D; Macara IG
Oncogene; 1990 Apr; 5(4):467-74. PubMed ID: 2158036
[TBL] [Abstract][Full Text] [Related]
15. Modification of carboxyl-terminal region is the cause of activation of the src gene in avian sarcoma virus S2.
Ikawa S; Yamamoto T; Toyoshima K
Jpn J Cancer Res; 1986 Jul; 77(7):611-4. PubMed ID: 3017908
[TBL] [Abstract][Full Text] [Related]
16. Properties of tripartite chimeras between Src and Lck.
Kashishian A; MacAuley A; Cooper JA
Oncogene; 1990 Oct; 5(10):1463-70. PubMed ID: 2250908
[TBL] [Abstract][Full Text] [Related]
17. In vivo phosphorylation states and kinase activities of transforming p60c-src mutants.
Jove R; Hanafusa T; Hamaguchi M; Hanafusa H
Oncogene Res; 1989; 5(1):49-60. PubMed ID: 2476707
[TBL] [Abstract][Full Text] [Related]
18. Product of vav proto-oncogene defines a new class of tyrosine protein kinase substrates.
Bustelo XR; Ledbetter JA; Barbacid M
Nature; 1992 Mar; 356(6364):68-71. PubMed ID: 1311423
[TBL] [Abstract][Full Text] [Related]
19. Induction of tumor formation and cell transformation by polyoma middle T antigen in the absence of Src.
Thomas JE; Aguzzi A; Soriano P; Wagner EF; Brugge JS
Oncogene; 1993 Sep; 8(9):2521-9. PubMed ID: 7689725
[TBL] [Abstract][Full Text] [Related]
20. The amino-terminal region of pp60c-src has a modulatory role and contains multiple sites of tyrosine phosphorylation.
Espino PC; Harvey R; Schweickhardt RL; White GA; Smith AE; Cheng SH
Oncogene; 1990 Mar; 5(3):283-93. PubMed ID: 1690377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
